Hexagon Capital Partners’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-186
| Closed | -$340 | – | 1457 |
|
|
2024
Q1 | $340 | Hold |
186
| – | – | ﹤0.01% | 1364 |
|
|
2023
Q4 | $231 | Hold |
186
| – | – | ﹤0.01% | 1349 |
|
|
2023
Q3 | $212 | Hold |
186
| – | – | ﹤0.01% | 1332 |
|
|
2023
Q2 | $170 | Hold |
186
| – | – | ﹤0.01% | 1357 |
|
|
2023
Q1 | $104 | Hold |
186
| – | – | ﹤0.01% | 1391 |
|
|
2022
Q4 | $107 | Hold |
186
| – | – | ﹤0.01% | 1411 |
|
|
2022
Q3 | $0 | Hold |
186
| – | – | ﹤0.01% | 1282 |
|
|
2022
Q2 | $0 | Hold |
186
| – | – | ﹤0.01% | 1164 |
|
|
2022
Q1 | $0 | Hold |
186
| – | – | ﹤0.01% | 912 |
|
|
2021
Q4 | $0 | Hold |
186
| – | – | ﹤0.01% | 841 |
|
|
2021
Q3 | $1K | Hold |
186
| – | – | ﹤0.01% | 788 |
|
|
2021
Q2 | $1K | Hold |
186
| – | – | ﹤0.01% | 749 |
|
|
2021
Q1 | $0 | Hold |
186
| – | – | ﹤0.01% | 736 |
|
|
2020
Q4 | $0 | Hold |
186
| – | – | ﹤0.01% | 710 |
|
|
2020
Q3 | $0 | Buy |
+186
| New | – | ﹤0.01% | 682 |
|